Question 1

Has Amy Curran received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $25,337 in general payments to Amy Curran across 80 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Amy Curran did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Amy Curran come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Johnson & Johnson(2 entities)	36	$24,379
E.r. Squibb & Sons, L.L.C.	8	$141
AstraZeneca	2	$130
AbbVie	1	$114
Amgen	5	$80
Seagen Inc.	2	$73
EMD Serono, Inc.	4	$65
Genentech USA, Inc.	3	$48
Pfizer	3	$45
Lilly USA, LLC	3	$41
Merck	3	$41
Boston Scientific	1	$40
Dova Pharmaceuticals	2	$39
GSK	2	$33
Foundation Medicine, Inc.	2	$28
Clovis Oncology, Inc.	1	$15
Gilead	1	$12
Teva Pharmaceuticals USA, Inc.	1	$12

Amy Curran

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Other medical oncology in Bryn Mawr